CAMBRIDGE, Mass., April 22, 2021 /PRNewswire/ -- Blueprint
Medicines Corporation (NASDAQ: BPMC), today announced that it will
host a live conference call and webcast at 8:30 a.m. ET on
Thursday, April 29, 2021 to report
its first quarter 2021 financial results and provide a corporate
update.
To access the live conference call, please dial (855) 728-4793
(domestic) or (503) 343-6666 (international), and refer to
conference ID 9292306. A webcast of the call will also be available
under "Events and Presentations" in the Investors & Media
section of the Blueprint Medicines website at
http://ir.blueprintmedicines.com/. The archived webcast will be
available on Blueprint Medicines' website approximately two hours
after the conference call and will be available for 30 days
following the call.
About Blueprint Medicines
Blueprint Medicines is a global precision therapy company
that invents life-changing therapies for people with cancer and
hematologic disorders. Applying an approach that is both precise
and agile, we create medicines that selectively target genetic
drivers, with the goal of staying one step ahead across stages of
disease. Since 2011, we have leveraged our research platform,
including expertise in molecular targeting and world-class drug
design capabilities, to rapidly and reproducibly translate science
into a broad pipeline of precision therapies. Today, we are
delivering approved medicines directly to patients in the
United States and Europe, and we are globally advancing
multiple programs for genomically defined cancers, systemic
mastocytosis, and cancer immunotherapy. For more information,
visit www.BlueprintMedicines.com and follow us
on Twitter (@BlueprintMeds) and LinkedIn.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/blueprint-medicines-to-report-first-quarter-2021-financial-results-on-thursday-april-29-2021-301274627.html
SOURCE Blueprint Medicines Corporation